Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in painful distal diabetic neuropathy with two titration schemes
2005-005788-27Phase 3Completed
- Sponsor
- Schwarz Pharma
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lacosamide in Diabetic Peripheral Neuropathy (DPN) (4 arms), sponsored by Schwarz Pharma. Primary endpoint: Primary efficacy endpoint. Started Apr 2006; status: completed.
02
Drugs
lacosamide
03
Conditions
Diabetic Peripheral Neuropathy (DPN)
Beyond the preview
Go deeper on 2005-005788-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005788-27.